Obalon Therapeutics Inc (OBLN)
Obalon Therapeutics Inc
NASDAQ:OBLN (6/15/2021, 7:00:01 PM)
After market: 3.12 +0.07 (+2.3%)3.05
-0.19 (-5.86%)
Company Profile
Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The company is headquartered in Carlsbad, California and currently employs 2 full-time employees. The company went IPO on 2016-10-06. The firm's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients. The Obalon balloon system is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed six months after the first balloon is placed. The Obalon balloon system intends to provide patients and physicians with a reversible and repeatable weight loss solution in an outpatient setting, without altering patient anatomy or requiring surgery. The firm has received Premarket approval (PMA) for its Obalon balloon system based on the results of its United States pivotal clinical trial, referred to as the SMART trial.
Company Info
Obalon Therapeutics Inc
5421 Avenida Encinas Ste F
Carlsbad CALIFORNIA 92008
P: 18584802400.0
CEO: Andrew Rasdal
Employees: 2.0
Website: http://www.obalon.com/
OBLN News
3 years ago - PennyStocks.com4 Penny Stocks Reddit Traders Are Buying Right NowLooking for penny stocks to buy on Reddit? Check these 4 out for your watchlist
3 years ago - ReShape Lifesciences Inc.ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending MergerSAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 8, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today that the parties anticipate the closing of their previously announced merger to occur promptly after approval of their pending Nasdaq listing application. While there can be no assurance that the listing application will be approved, Nasdaq approval is the sole remaining condition to
3 years ago - PennyStocks.comPenny Stocks Are Heating Up, Here’s 3 You Need to Know AboutAre these the best penny stocks to watch right now? Take a look and decide for yourself
3 years ago - ReShape Lifesciences Inc.Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape LifesciencesSAN DIEGO, CA / ACCESSWIRE / May 24, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special
3 years ago - PennyStocks.comTop Penny Stocks to Buy Today? Here’s 3 to Watch in 2021Top penny stocks to buy today? Check these 3 out for your watchlist
3 years ago - ReShape Lifesciences Inc.Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape LifesciencesSAN DIEGO, CA / ACCESSWIRE / May 21, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled intragastric balloon system for the treatment of obesity, is taking this opportunity to remind its stockholders to vote on all the proposals related to the proposed merger with ReShape Lifesciences Inc. in advance of the upcoming reconvened special
OBLN Twits
Here you can normally see the latest stock twits on OBLN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
